(ANSA) - BRUSSELS, APRIL 07 - "The benefits" of the AstraZeneca vaccine "outweigh the risks". The EMA reiterates this in a note, however, advising to "seek medical assistance immediately if people develop symptoms of blood clots and low platelets" after the vaccine. For the Ema, however, "there are no generalized risks in the administration therefore no specific measures will be recommended to reduce the risk".
However, the information "in the leaflet will be updated and" warnings "will be disseminated. In addition," there has been no evidence of age "between the rare events of thrombosis and AstraZeneca, said the director of EMA, Emer Cooke. (ANSA) .